Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network

被引:0
作者
Deborah A. Bilder
Amanda V. Bakian
David A. Stevenson
Paul S. Carbone
Christopher Cunniff
Alyson B. Goodman
William M. McMahon
Nicole P. Fisher
David Viskochil
机构
[1] University of Utah,Utah Autism Research Program, Department of Psychiatry
[2] University of Utah,Division of Medical Genetics
[3] University of Utah,Department of Pediatrics
[4] University of Arizona,Department of Pediatrics
[5] Center for Disease Control and Prevention,National Center on Birth Defects and Developmental Disabilities
[6] University of Utah,Department of Psychiatry
[7] Stanford University,Division of Medical Genetics
[8] Weill Cornell Medical College,Division of Medical Genetics
来源
Journal of Autism and Developmental Disorders | 2016年 / 46卷
关键词
Autism; Neurofibromatosis; Developmental disabilities; Children; Non-verbal communications;
D O I
暂无
中图分类号
学科分类号
摘要
Neurofibromatosis type 1 (NF1) is an inherited neurocutaneous disorder associated with neurodevelopmental disorders including autism spectrum disorder (ASD). The frequency of ASD/NF1 co-occurrence has been subject to debate since the 1980s. This relationship was investigated in a large population-based sample of 8-year-old children identified with ASD (N = 12,271) by the Centers for Disease Control and Prevention’s Autism and Developmental Disabilities Monitoring (ADDM) Network. Twenty-two (1-in-558) children with ASD had diagnosed NF1, exceeding NF1 general population estimates by four to five fold. Children with ASD/NF1 versus ASD without NF1 were significantly less likely to receive a community-based ASD diagnosis (p = 0.04) and understand non-verbal communication (p = 0.001). These findings underscore the importance of including social-communication ability among relevant developmental concerns in children with NF1.
引用
收藏
页码:3369 / 3376
页数:7
相关论文
共 108 条
[1]  
Brei NG(2007) Prevalence of autism spectrum disorders–autism and developmental disabilities monitoring network, 14 sites, United States, 2002 Morbidity and Mortality Weekly Report 56 12-28
[2]  
Klein-Tasman BP(2009)Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, United States, 2006 Morbidity and Mortality Weekly Report 58 1-20
[3]  
Schwarz NG(2012)Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008 Morbidity and Mortality Weekly Report 61 1-19
[4]  
Casnar CL(2014)Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010 Morbidity and Mortality Weekly Report 63 1-21
[5]  
DeBella K(2014)Language in young children with neurofibromatosis-1: Relations to functional communication, attention, and social functioning Research in Developmental Disabilities 35 2495-2504
[6]  
Szudek J(2000)Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children Pediatrics 105 608-614
[7]  
Friedman JM(1996)Children and adolescents with neurofibromatosis 1: A behavioral phenotype Journal of Developmental and Behavioral Pediatrics 17 229-239
[8]  
Dilts CV(1997)Autism and associated medical disorders in a French epidemiological survey Journal of the American Academy of Child and Adolescent Psychiatry 36 1569-1591
[9]  
Carey JC(2013)Neurofibromatosis type 1 and autism spectrum disorder Pediatrics 132 e1642-e1648
[10]  
Kircher JC(2013)Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study Developmental Medicine and Child Neurology 55 139-145